X
Archive by tag: LLPReturn

Does The Coronavirus Pandemic Constitute A Material Adverse Effect?

As COVID-19 – commonly known as coronavirus – continues to send shock waves through global markets and industries, dealmakers are considering whether they can terminate, or renegotiate, M&A transactions that they have entered into but have not yet...By: White and Williams LLP
Read More
White and Williams LLP | Mar 16,2020 |

The Short-Term Impact of Coronavirus on Deal Activity

Speculation about the impact of coronavirus and recent stock market volatility, including Thursday’s worst decline since the 1987 market crash, on M&A activity has intensified. Members of Ballard Spahr’s Mergers & Acquisitions Group report seeing the...By: Ballard Spahr LLP
Read More
Ballard Spahr LLP | Mar 16,2020 |

President Trump Orders Divestment of U.S. Company; CFIUS Clears Semiconductor Transaction

It has been an active last week in the world of the Committee on Foreign Investment in the United States (“CFIUS”). In addition to CFIUS’s publication of proposed regulations that would impose filing fees for parties’ submission of notices of...By: Orrick, Herrington & Sutcliffe LLP
Read More

M&A is top of mind: Will dealmakers actually double down in a downturn? Shareholder activism changes everything

Activism affects virtually everyone now—even those who may never have to deal with an activist - If you’re still nursing doubts about whether activism has a broad effect on M&A, it may be time to put them to bed. Seventy-eight percent of respondents...By: White & Case LLP
Read More
White & Case LLP | Mar 16,2020 |

M&A MAC Clauses – Implications of Coronavirus

Trends in Material Adverse Change Clauses – Implications of Coronavirus on M&A Transactions - On M&A transactions deal certainty may be a key negotiation issue. Whilst a seller may be reluctant to concede a material adverse change (MAC) or material...By: White & Case LLP
Read More
White & Case LLP | Mar 14,2020 |

M&A in the Time of COVID-19

Thinking through the impact of coronavirus (COVID-19) on M&A and deal terms. COVID-19 may cause buyers and sellers to reassess valuations, adjust pricing mechanisms and implement new methodologies for interim operations and crisis response...By: Pillsbury Winthrop Shaw Pittman LLP
Read More

New International Arbitration Study Offers Construction Dispute Insight

On Nov. 21, the Queen Mary University of London School of International Arbitration, in partnership with the U.K.-based law firm Pinsent Masons LLP, released its ninth annual international arbitration survey focused on international construction...By: Pepper Hamilton LLP
Read More
Pepper Hamilton LLP | Mar 13,2020 |

M&A is top of mind: Will dealmakers actually double down in a downturn? Dealmakers plan to lean into a downturn

Half of the executives in our survey expect to do more deals if there's a downturn in 2020 than if there isn't. Dealmakers were optimistic heading into 2020. The coronavirus outbreak has changed things, but we believe that most of what we heard from...By: White & Case LLP
Read More
White & Case LLP | Mar 13,2020 |

Does The COVID-19 Outbreak Constitute A Material Adverse Effect? Plus Other Impacts On M&A Transactions

MAE. In any M&A transaction, a significant deterioration in the target’s business between signing and closing may upset the fundamental bargain struck between a seller and a buyer. M&A agreements typically address this risk through highly negotiated...By: Vinson & Elkins LLP
Read More
Vinson & Elkins LLP | Mar 13,2020 |

Healthcare & Life Sciences Private Equity Deal Tracker: Veritas Capital to Acquire DXC Technology Healthcare Unit for $5 Billion

DXC Technology has announced it will sell its healthcare technology business to Veritas Capital....By: McGuireWoods LLP
Read More
McGuireWoods LLP | Mar 13,2020 |
Page 149 of 484 [149]